Vertebral Fracture Assessment Increases Use of Pharmacologic Therapy for Fracture Prevention in Clinical Practice.

DXA FRACTURE PREVENTION MEDICATION FRACTURE RISK ASSESSMENT HEALTH SERVICES RESEARCH SCREENING THERAPEUTICS (OTHER) VERTEBRAL FRACTURE ASSESSMENT

Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640

Informations de publication

Date de publication:
12 2019
Historique:
received: 05 04 2019
revised: 10 07 2019
accepted: 18 07 2019
pubmed: 2 8 2019
medline: 12 9 2020
entrez: 2 8 2019
Statut: ppublish

Résumé

The impact of vertebral fracture assessment (VFA) on lateral spine images in clinical practice on subsequent patient use of fracture prevention medication is unknown. Our objective was to determine the association of prevalent vertebral fracture identified on bone density lateral spine images (positive VFA) with subsequent use of fracture prevention therapy in usual clinical practice, using the Manitoba Bone Density Program database prospective observational cohort. Since 2010, targeted VFA imaging has been done at the time of bone densitometry in Manitoba for 21% of women and men meeting criteria based on age, bone mineral density (BMD), height loss, and glucocorticoid use. Among 6652 treatment-naive individuals with at least 90 days follow-up who had VFA imaging, 923 (13.9%) had one or more definite vertebral fractures identified using a modified algorithm-based qualitative (ABQ) method. For those with a positive VFA, their bone density reports stated the patient was at high risk of subsequent fracture and qualified for fracture prevention therapy. Subsequent osteoporosis treatment initiated within the next 12 months was identified using population-based pharmacy data. Logistic regression models were used to estimate the association of positive VFA with subsequent prescription (Rx), compared to negative VFA. Fracture prevention medication was started by 2127 (32%) individuals, 52.3% with positive versus 28.4% with negative VFA (p value <0.001). This association was substantially stronger in those designated (before VFA results were known) to have low or moderate fracture risk compared to high fracture risk (interaction p value <0.001), and in those with osteopenia (OR 4.51; 95% CI, 3.48 to 5.85) compared to those with osteoporosis by BMD criteria (OR 1.72; 95% CI, 1.43 to 2.08, interaction p value <0.001). Targeted VFA imaging at the time of bone densitometry substantially improves identification of those at high fracture risk and fracture prevention medication use among those with prevalent vertebral fracture. © 2019 American Society for Bone and Mineral Research. © 2019 American Society for Bone and Mineral Research.

Identifiants

pubmed: 31369164
doi: 10.1002/jbmr.3836
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2205-2212

Informations de copyright

© 2019 American Society for Bone and Mineral Research.

Références

Harvey NCW, McCloskey EV, Mitchell PJ, et al. Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. 2017;28(5):1507-29.
Nayak S, Greenspan SL. How can we improve osteoporosis care? A systematic review and meta-analysis of the efficacy of quality improvement strategies for osteoporosis. J Bone Miner Res. 2018;33(9):1585-94.
Ferrar L, Roux C, Felsenberg D, Gluer CC, Eastell R. Association between incident and baseline vertebral fractures in European women: vertebral fracture assessment in the Osteoporosis and Ultrasound Study (OPUS). Osteoporos Int. 2012;23(1):59-65.
Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH. Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int. 2007;18(6):761-70.
Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14(5):821-8.
Schousboe JT, Vo T, Taylor BC, et al. Prediction of incident major osteoporotic and hip fractures by trabecular bone score (TBS) and prevalent radiographic vertebral fracture in older men. J Bone Miner Res. 2016;31(3):690-7.
Compston J, Cooper A, Cooper C, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43.
Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359-81.
Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182(17):1864-73.
Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ 3rd. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res. 1992;7(2):221-7.
Fink HA, Milavetz DL, Palermo L, et al. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa. J Bone Miner Res. 2005;20(7):1216-22.
Ensrud KE, Blackwell TL, Fink HA, et al. What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res. 2016;31(8):1500-3.
Malgo F, Hamdy NAT, Ticheler C, et al. Value and potential limitations of vertebral fracture assessment (VFA) compared to conventional spine radiography: experience from a fracture liaison service (FLS) and a meta-analysis. Osteoporos Int. 2017;28(10):2955-65.
Lee JH, Lee YK, Oh SH, et al. A systematic review of diagnostic accuracy of vertebral fracture assessment (VFA) in postmenopausal women and elderly men. Osteoporos Int. 2016;27(5):1691-9.
McCloskey EV, Vasireddy S, Threlkeld J, et al. Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis. J Bone Miner Res. 2008;23(10):1561-8.
Schousboe JT, Lix LM, Morin SN, et al. Prevalent vertebral fracture on bone density lateral spine (VFA) images in routine clinical practice predict incident fractures. Bone. 2019;121:72-9.
Prince RL, Lewis JR, Lim WH, et al. Adding lateral spine imaging for vertebral fractures to Densitometric screening: Improving ascertainment of patients at high risk of incident osteoporotic fractures. J Bone Miner Res. 2019;34(2):282-9.
Jager PL, Jonkman S, Koolhaas W, Stiekema A, Wolffenbuttel BH, Slart RH. Combined vertebral fracture assessment and bone mineral density measurement: a new standard in the diagnosis of osteoporosis in academic populations. Osteoporos Int. 2011;22(4):1059-68.
Schousboe J, McKiernan F, Fuehrer J, Binkley N. Use of a performance algorithm improves utilization of vertebral fracture assessment in clinical practice. Osteoporos Int. 2014;25(3):965-72.
Leslie WD, MacWilliam L, Lix L, Caetano P, Finlayson GS. A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int. 2005;16(7):773-82.
Leslie WD, Caetano PA, Macwilliam LR, Finlayson GS. Construction and validation of a population-based bone densitometry database. J Clin Densitom. 2005;8(1):25-30.
Schousboe JT, Ensrud KE, Nyman JA, Kane RL, Melton LJ 3rd. Cost-effectiveness of vertebral fracture assessment to detect prevalent vertebral deformity and select postmenopausal women with a femoral neck T-score > −2.5 for alendronate therapy: a modeling study. J Clin Densitom. 2006;9(2):133-43.
Jiang G, Eastell R, Barrington NA, Ferrar L. Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int. 2004;15(11):887-96.
Lentle B, Trollip J, Lian K. The radiology of osteoporotic vertebral fractures redux. J Clin Densitom. 2016;19(1):40-7.
Lentle BC, Berger C, Probyn L, et al. Comparative analysis of the radiology of osteoporotic vertebral fractures in women and men: cross-sectional and longitudinal observations from the Canadian Multicentre Osteoporosis Study (CaMos). J Bone Miner Res. 2018;33(4):569-79.
Leslie WD, Lix LM, Johansson H, et al. Independent clinical validation of a Canadian FRAX tool: fracture prediction and model calibration. J Bone Miner Res. 2010;25(11):2350-8.
Fraser LA, Langsetmo L, Berger C, et al. Fracture prediction and calibration of a Canadian FRAX(R) tool: a population-based report from CaMos. Osteoporos Int. 2011;22(3):829-37.
Leslie WD, Lix LM, Langsetmo L, et al. Construction of a FRAX(R) model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int. 2011;22(3):817-27.
Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286(22):2815-22.
Leslie WD, Morin S. Fracture burden in relation to low bone mineral density and FRAX((R)) probability. J Clin Densitom. 2011;14(3):279-85.
Kanis JA, Barton IP, Johnell O. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture. Osteoporos Int. 2005;16(5):475-82.
Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535-41.
Crandall CJ, Newberry SJ, Diamant A, et al. Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med. 2014;161(10):711-23.
Marcus R, Wang O, Satterwhite J, Mitlak B. The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res. 2003;18(1):18-23.
Harvey NC, Kanis JA, Oden A, et al. FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Osteoporos Int. 2015;26(11):2677-84.
Yu J, Brenneman SK, Sazonov V, Modi A. Reasons for not initiating osteoporosis therapy among a managed care population. Patient Prefer Adherence. 2015;9:821-30.
Khosla S, Shane E. A crisis in the treatment of osteoporosis. J Bone Miner Res. 2016;31(8):1485-7.
Schousboe JT, Davison ML, Dowd B, Thiede Call K, Johnson P, Kane RL. Predictors of patients' perceived need for medication to prevent fracture. Med Care. 2011;49(3):273-80.
Rosen HN, Vokes TJ, Malabanan AO, et al. The official positions of the International Society for Clinical Densitometry: vertebral fracture assessment. J Clin Densitom. 2013;16(4):482-8.
Fink HA, Harrison SL, Taylor BC, et al. Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures. J Clin Densitom. 2008;11(2):250-9.
Aubry-Rozier B, Fabreguet I, Iglesias K, Lamy O, Hans D. Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies. Osteoporos Int. 2017;28(2):523-7.
Chou SH, Vokes TJ, Ma SL, Costello M, Rosen HR, Schousboe JT. Simplified criteria for selecting patients for vertebral fracture assessment. J Clinical Densitom. 2014;17(3):386-91.
Genant HK, Li J, Wu CY, Shepherd JA. Vertebral fractures in osteoporosis a new method for clinical assessment. J Clin Densitom. 2000;3(3):281-90.
Rosen H, Vokes T, Malabanan A, et al. Indications for vertebral fracture assessment (VFA): 2013 ISCD official positions. J Clin Densitom. 2013;16(4) 482-4.
Casez P, Uebelhart B, Gaspoz JM, Ferrari S, Louis-Simonet M, Rizzoli R. Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists. Osteoporos Int. 2006;17(7):965-70.
Gruber M, Dinges J, Muller D, Baum T, Rummeny EJ, Bauer J. Impact of specific training in detecting osteoporotic vertebral fractures on routine chest radiographs. Rofo. 2013;185(11):1074-80.
Province of Manitoba. Manitoba Bone Density Program. Chronic Disease; Osteoporosis Guidelines for Testing. Winnipeg, MB, Canada: Province of Manitoba (cited 2019 Aug 4). Available from: https://www.gov.mb.ca/health/primarycare/providers/chronicdisease/bonedensity/index.html.

Auteurs

John T Schousboe (JT)

Park Nicollet Osteoporosis Center, Park Nicollet Clinic and HealthPartners Institute, Bloomington, MN, USA.
Division of Health Policy and Management, University of Minnesota, Minneapolis, MN, USA.

Lisa M Lix (LM)

Department of Medicine, University of Manitoba, Winnipeg, Canada.

Suzanne N Morin (SN)

Department of Medicine, McGill University, Montreal, Canada.

Sheldon Derkatch (S)

Department of Medicine, University of Manitoba, Winnipeg, Canada.

Mark Bryanton (M)

Department of Medicine, University of Manitoba, Winnipeg, Canada.

Mashael Alhrbi (M)

Department of Medicine, University of Manitoba, Winnipeg, Canada.

William D Leslie (WD)

Department of Medicine, University of Manitoba, Winnipeg, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH